Up Next
-
Part 1 | Session 16 The CLariTI Study: Natural Progression of CLTI
-
Part 1 | Session 17 PAD in Germany 2009-2018 With Dr Rammos
-
Part 1 | Session 18 LINC 22: IN.PACT Global Study 5-Y Diabetic & Gender Subgroup Outcomes
-
Part 1 | Session 19 Patient Selection in NIVL and Preventing Migration in Venous Stenting
-
Part 1 | Session 1 GPX Embolic Device In Peripheral Applications
-
Part 1 | Session 2 B-CLEAR Registry: Timing of TEVAR in Type B Aortic Dissection
-
Part 1 | Session 4 Cre8™ BTK Clinical Results in Complex BTK Patients
-
Part 1 | Session 5 AVF Formation with Adjuvant Endovascular Maturation
-
Part 1 | Session 6 Long-Term Results of Supera in AVF Junta-Anastomosis
-
Part 1 | Session 7 SirPAD RCT: Sirolimus-Coated DCBs in Pts with PAD
-
Part 1 | Session 8 PRELUDE-BTK With Dr Lichtenberg: Serranator® PTA in Pts With PAD
-
Part 1 | Session 9 PRIZER Study: Renzan™ Stent in Pts With PAD
-
Part 1 | Session 10 Auryon-SCE: Real-World Cohort Shows Promising Freedom from TLR at 6M
-
Part 1 | Session 11 JET-RANGER: Jetstream Atherectomy & DCB In Pts With Complex Calcified Lesions
-
Part 1 | Session 12 FLEX RCT: Micro-Incision prior to PTA in Pts With AVF
-
Part 1 | Session 13 BioMimics 3D Stent: Safety and Efficacy in Real-World Patients
-
Part 1 | Session 14 P-MAX Study with Dr Lichtenberg: ASPIREX®S Endovascular System
Overview
Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.